Image de couverture de livre

Fibrinogen‐like 1: A hepatokine linking liver physiology to hematology

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Jean Personnaz, Hervé Guillou, Léon Kautz
Format:	Artículo Open Access
Publié:	Wiley 2024
Sujets:	HemaSphere
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Promoting and supporting leadership in hematology departments
par: Roch Houot, et autres
Publié: (2024)

Harnessing the immunotherapeutic potentials of gamma delta T cells against hematological malignancies
par: Charles Agbuduwe, et autres
Publié: (2025)

Metabolism in hematology: Technological advances open new perspectives on disease biology and treatment
par: Eileen Haring, et autres
Publié: (2025)

Kinetics of hematologic response in AL amyloidosis: Insights from clinical and cytogenetic subgroup analysis in the daratumumab era
par: Abdul‐Hamid Bazarbachi, et autres
Publié: (2025)

An EHA strategic roadmap for improved care in Europe for AYA patients with malignant and chronic non‐malignant hematological diseases
par: Anna Castleton, et autres
Publié: (2026)

Biological and clinical characteristics of ETV6 :: RUNX1 ‐like ALL
par: Marketa Zaliova, et autres
Publié: (2026)

The oral ferroportin inhibitor vamifeport prevents liver iron overload in a mouse model of hemochromatosis
par: Naja Nyffenegger, et autres
Publié: (2024)

APL‐like subset within NPM1 ‐mutated AML: A distinct immunophenotype correlating with early vascular complications
par: Francesco Mannelli, et autres
Publié: (2026)

An integrated classification of tumor suppressor IKZF1 inactivation and oncogenic activation in Philadelphia chromosome‐like acute lymphoblastic leukemia
par: Zicong Huang, et autres
Publié: (2024)

Overcoming a T‐ALL order: A comprehensive study linking genomics to clinical outcomes
par: Yizhou Huang, et autres
Publié: (2024)

Parkinson‐like neurotoxicity in female patients treated with idecabtagene‐vicleucel
par: Audrey Couturier, et autres
Publié: (2024)

Persistent BCR::ABL1 ‐positive preleukemic stem cells drive late clonal evolution in Philadelphia chromosome‐positive ALL
par: Jean‐Edouard Martin, et autres
Publié: (2026)

TLX1 translocation variants and enhancer hijacking influence clinical outcome in T‐cell acute lymphoblastic leukemia
par: Estelle Balducci, et autres
Publié: (2025)

Efficacy of anti‐PD1 therapy in extranodal NK/T cell lymphoma: A matched cohort analysis from the LYSA
par: Amira Marouf, et autres
Publié: (2025)

Efficacy of erythroid‐stimulating agent and luspatercept in VEXAS syndrome: A multicenter retrospective study by the FRENVEX group
par: Maël Heiblig, et autres
Publié: (2025)

Extracellular vesicles from chronic lymphocytic leukemia cells promote leukemia aggressiveness by inducing the differentiation of monocytes into nurse‐like cells via an RNA‐dependent mechanism
par: Nathan Dubois, et autres
Publié: (2025)

Strengthening awareness and response to HTLV‐1 infection in Africa: A neglected threat to blood safety and public health
par: Jean‐Claude Twizere, et autres
Publié: (2025)

Analysis of immunoglobulin/T‐cell receptor repertoires by high‐throughput RNA sequencing reveals a continuous dynamic of positive clonal selection in follicular lymphoma
par: Victor Bobée, et autres
Publié: (2024)

Large B‐cell lymphoma (LBCL): EHA Clinical Practice Guidelines for diagnosis, treatment, and follow‐up
par: Catherine Thieblemont, et autres
Publié: (2025)

IDALLO study: A retrospective multicenter study of the SFGM‐TC evaluating the efficacy and safety of ivosidenib in relapsed IDH1‐mutated AML after allogeneic hematopoietic cell transplantation
par: Adrien Caillet, et autres
Publié: (2024)

Bridging gaps in clinical trial accessibility and reimbursement for large B‐cell lymphoma therapies across Europe
par: Florence Broussais, et autres
Publié: (2025)

Low‐risk MDS—A spotlight on precision medicine for SF3B1‐mutated patients
par: Shoshana Burke, et autres
Publié: (2025)

Disease characteristics and outcomes of acute myeloid leukemia in germline RUNX1 deficiency (Familial Platelet Disorder with associated Myeloid Malignancy)
par: Martijn P. T. Ernst, et autres
Publié: (2025)

Impact of second autologous stem‐cell transplantation at relapsed multiple myeloma: A French multicentric real‐life study
par: Axel André, et autres
Publié: (2024)

NOTCH1 fusions in pediatric T‐cell lymphoblastic lymphoma: A high‐risk subgroup with CCL17 (TARC) levels as diagnostic biomarker
par: Emma Kroeze, et autres
Publié: (2024)

A novel MYB::PAIP1 oncogenic fusion in pediatric blastic plasmacytoid dendritic cell neoplasm (BPDCN) is dependent on BCL2 expression and is sensitive to venetoclax
par: Hansen J. Kosasih, et autres
Publié: (2024)

Unraveling the role of TP53 mutations in myeloproliferative neoplasms: Molecular mechanisms of leukemic transformation
par: Suzana da Silva‐Benedito, et autres
Publié: (2026)

A pooled analysis of 3 large multicenter trials confirms a survival advantage for NPM1 mut AML in MRD neg remission after intensive induction
par: Konstanze Döhner, et autres
Publié: (2025)

Hyperdiploid acute lymphoblastic leukemia in children with LZTR1 germline variants
par: Lisa Zipper, et autres
Publié: (2024)

Outcomes and treatment patterns of patients with primary mediastinal B‐cell lymphoma after CAR‐T cell therapy failure: A DESCAR‐T analysis
par: Jean Galtier, et autres
Publié: (2025)

Upregulation of ALDH1 as an adaptive epigenetic response to anthracyclines in acute myeloid leukemia
par: Francesco Leonetti, et autres
Publié: (2025)

Cell surface surprise: NPM1 is an immune therapy target for acute myeloid leukemia
par: Hansen J. Kosasih, et autres
Publié: (2025)

Optimizing therapy for relapsed/refractory classic Hodgkin lymphoma in the era of PD‐1 blockade
par: Thomas M. Kuczmarski, et autres
Publié: (2025)

Combined inhibition of CTPS1 and ATR is a metabolic vulnerability in p53‐deficient myeloma cells
par: Romane Durand, et autres
Publié: (2024)

Dynamic evolution of TCF3‐PBX1 leukemias at the single‐cell level under chemotherapy pressure
par: Mira Kusterer, et autres
Publié: (2025)

Impact of myelodysplasia‐related and additional gene mutations in intensively treated patients with NPM1‐mutated AML
par: Sibylle Cocciardi, et autres
Publié: (2025)

Intra‐subtype heterogeneity shapes treatment response in KMT2A ‐rearranged ALL across all age groups
par: Alina M. Hartmann, et autres
Publié: (2026)

Casein kinase 1δ/ε inhibition suppresses CLL proliferation through cell‐intrinsic and microenvironmental mechanisms
par: Antonia Mikulova, et autres
Publié: (2026)

Implementation science in hemato‐oncology molecular diagnostics in France via the Groupe des Biologistes Moléculaire des Hémopathies Malignes (GBMHM)
par: Jean‐Michel Cayuela, et autres
Publié: (2025)

Additive effect of multiple genetic variants in SEC23B and PIEZO1 on iron metabolism dyshomeostasis in hereditary anemias
par: Antonella Nostroso, et autres
Publié: (2026)